The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Gösta Gahrton

Karolinska Institutet

Department of Medicine and Karolinska University Hospital

Huddinge

SE 14186 Stockholm

Sweden

[email]@medhs.ki.se

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Karolinska Institutet, Department of Medicine and Karolinska University Hospital, Huddinge, SE 14186 Stockholm, Sweden. 2005 - 2007
  • Department of Hematology, Karolinska Institute, Huddinge, Sweden. 1998 - 2004
  • Department of Medicine, Huddinge Hospital, Sweden. 2001

References

  1. Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation. Gahrton, G. Best. Pract. Res. Clin. Haematol (2007) [Pubmed]
  2. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Gahrton, G., Iacobelli, S., Apperley, J., Bandini, G., Björkstrand, B., Bladé, J., Boiron, J.M., Cavo, M., Cornelissen, J., Corradini, P., Kröger, N., Ljungman, P., Michallet, M., Russell, N.H., Samson, D., Schattenberg, A., Sirohi, B., Verdonck, L.F., Volin, L., Zander, A., Niederwieser, D. Bone Marrow Transplant. (2005) [Pubmed]
  3. Progress in hematopoietic stem cell transplantation in multiple myeloma. Gahrton, G. Curr. Opin. Hematol. (2005) [Pubmed]
  4. New therapeutic targets in multiple myeloma. Gahrton, G. Lancet (2004) [Pubmed]
  5. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Gahrton, G., Svensson, H., Cavo, M., Apperly, J., Bacigalupo, A., Björkstrand, B., Bladé, J., Cornelissen, J., de Laurenzi, A., Facon, T., Ljungman, P., Michallet, M., Niederwieser, D., Powles, R., Reiffers, J., Russell, N.H., Samson, D., Schaefer, U.W., Schattenberg, A., Tura, S., Verdonck, L.F., Vernant, J.P., Willemze, R., Volin, L. Br. J. Haematol. (2001) [Pubmed]
  6. High-dose treatment of multiple myeloma. Gahrton, G., Björkstrand, B. Crit. Rev. Oncol. Hematol. (1999) [Pubmed]
  7. Gene marking and gene therapy in multiple myeloma. Gahrton, G., Björkstrand, B., Dilber, M.S., Sundman-Engberg, B., Ljungman, P., Smith, C.I. Adv. Exp. Med. Biol. (1998) [Pubmed]
 
WikiGenes - Universities